Thc Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended January 31, 2020
March 23, 2020 at 02:03 pm EDT
Share
THC Therapeutics, Inc. announced earnings results for the second quarter ended January 31, 2020. For the second quarter, the company announced operating loss was USD 394,947 compared to USD 2.697 million a year ago. Net loss was USD 867,039 compared to USD 3.543 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to USD 0.27 a year ago. For the half year, operating loss was USD 567,204 compared to USD 3.104 million a year ago. Net loss was USD 1.012 million compared to USD 3.982 million a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.31 a year ago.
THC Therapeutics, Inc. is focused on developing a sanitizing herb dryer, the dHydronator, with multiple design, function, and usage patents. The dHydronator product is specifically designed for the drying and sanitizing (i.e., reducing the bacterial count by using ultraviolet light) of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The dHydronator can reduce the moisture content of cannabis to 10-15% in only 10-14 hours. The dHydronator can also reduce the bacterial count of the cannabis during the drying process. The Company operates in the wellness industry.
THC THERAPEUTICS, INC. 
